Laparoscopic sleeve gastrectomy for treatment of type 2 diabetes mellitus in adolescents

• Ngā kaituhi matua: Mohamed Saber Mostafa (Author), Ahmed Abdelhaseeb Youssef (Author), Mohamed Hisham Soliman (Author)
• Hōputu: Pukapuka
• I whakaputaina: SpringerOpen, 2022-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.
• Notes: 10.1186/s43159-021-00139-y; 2090-5394
• Keywords: Pediatrics; RJ1-570; Surgery; RD1-811
• Source: Annals of Pediatric Surgery, Vol 18, Iss 1, Pp 1-5 (2022)

Abstract Background Metabolic diseases have been associated with childhood obesity no longer restricted to adults as previously known. Hypertension and diabetes mellitus (DM) have been reported in children with morbid obesity. Laparoscopic sleeve gastrectomy (LSG) has been used as a primary procedure for weight control among children and adolescents with acceptable records of effective weight loss together with evidence of improvement of associated co-morbidities. Results Thirty-two patients were diagnosed with morbid obesity and DM presented to obesity and nutrition clinic and were included in this study. Laparoscopic sleeve gastrectomy (LSG) was the chosen operation to treat their obesity and associated co-morbidities. Fasting blood sugar and HbA1c were measured before the operation and 1 year after surgery. Twenty-seven patients had significant improvement of their glycemic profile and managed to stop the hypoglycemic medication. Conclusion LSG may play an important role as a metabolic control procedure rather than a bariatric restrictive procedure only.